Rua Releases Market Insights 2023

Rua Bioscience has released its Market Insights for 2023.

The update is designed to share information about the challenges and opportunities presented by emerging high-value medicinal cannabis markets. 

CEO, Paul Naske, says “as we progress conversations and negotiations in Europe, our understanding of global medicinal cannabis markets evolves. This update provides an opportunity for Rua to share some of our most recent findings, focusing on Europe, Australia and New Zealand.”

The update is released as the company prepares for the launch of its first medicine in Germany.

Read Rua Market insights 2023 here.

Previous
Previous

Rua Accelerates Export Strategy, Ceases Manufacturing

Next
Next

Rua Releases Half-Year Result – Results as expected, with German launch imminent